危険とリスクの違い:毒理学的研究で流行している用量範囲と,実生活での香水曝露の違い

Kaushal Joshi¹, Arianna Bartlett¹, Wolfgang Dekant²

¹Research Institute for Fragrance Materials, Mahwah, New Jersey, United States of America.

Regulatory toxicology and pharmacology : RTP

|February 21, 2026

まとめ

フレグランスの安全性が最優先です. リスク評価によると,動物実験における毒性量は,食品や香水の使用によるヒトの典型的な暴露をはるかに上回り,消費者の安全性を保証しています.

科学分野:

毒理学毒理学毒理学
リスク評価リスク評価
エクスポージャー・サイエンスの科学

背景:

フレグランスの安全性は,消費者と産業にとって重要な懸念事項です.
フレグランス材料研究所 (RIFM) は,透明なリスク評価枠組みを採用しています.
歴史的に,全身性毒性評価は動物研究に基づいていたが,RIFMは10年以上にわたって新しい試験を実施していない.

研究の目的:

フレグランス成分に対する現実的なヒト被曝レベル内で動物への毒性データを文脈化します.
動物実験で使用された投与量と日常的なヒトの被曝量の有意な違いを例示します.
信頼性の高いリスク評価において,被曝科学の応用を実証する.

主な方法:

ベンザルデヒドおよびp-cymeneの観察されていない有害効果レベル (NOAEL) およびヒト等価用量 (HED) を決定した.
食品と香水の摂取データを比較基準として使用した.
フレグランス曝露の評価のために,Creme RIFM総曝露モデルを使用しました.

主要な成果:

副作用のレベルは,毎日非常に大量のアーモンドやラズベリーを摂取することを必要とします.
フレグランスの使用によって有毒レベルを達成するには,非現実的な数の毎日のアプリケーション (数十万のスプレー) が必要になります.
計算されたNOAELとHED値は,動物実験用量とヒトへの曝露の間の実質的な安全限界を強調しています.

結論:

動物実験のデータは,現実的なヒトの被曝シナリオを考慮して解釈されなければならない.
曝露科学の進歩は,正確で有意義な香水のリスク評価に不可欠です.
現在のリスク評価の実践は,消費者のための香水の成分の安全性を保証します.

さらに関連する動画

08:23

An Automated Microscopic Scoring Method for the γ-H2AX Foci Assay in Human Peripheral Blood Lymphocytes

Published on: December 25, 2021

5.4K

10:10

Assessment of the Acute Inhalation Toxicity of Airborne Particles by Exposing Cultivated Human Lung Cells at the Air-Liquid Interface

Published on: February 23, 2020

7.6K

関連する概念動画

01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

01:12

Hazard Ratio

650

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...

650

01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

500

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

500

01:11

Hazard Rate

460

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...

460

01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...

01:12

Relative Risk

2.3K

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...